New directions in the treatment of antidepressant-induced sexual dysfunction

Clinical Therapeutics

Volumn 22, Issue SUPPL. A, 2000, Pages

  Rothschild, Anthony J ^a   Irving, S ^a   Brudnick, Betty ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bupropion; Buspirone; Nefazodone; Sexual dysfunction; Sildenafil citrate; SSRIs; Yohimbine

Indexed keywords

AMANTADINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CLOMIPRAMINE; CYPROHEPTADINE; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; NEFAZODONE; PAROXETINE; PEMOLINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; VENLAFAXINE; YOHIMBINE;

ANAMNESIS; CONFERENCE PAPER; DEPRESSION; DOCTOR PATIENT RELATION; FEMALE; HUMAN; MALE; RATING SCALE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; TREATMENT PLANNING;

EID: 0034119508     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80072-7     Document Type: Conference Paper

References (51)

1. National Institute of Mental Health. The Numbers Count: Mental Illness in America. 1999. Available at: http://www. nimh.nih.gov/publicat/numbers.cfm. Accessed January 12, 2000.
2. Agency for Health Care Policy and Research. Clinical Practice Guideline Number 5: Depression in Primary Care. Volume I. Detection and Diagnosis. US DHHS. 1993. Available at: http://text.n/m. gov/ahcpr/dep/www/deplctxt.html. Accessed January 11, 2000.
3. Saks BR. Identifying and discussing sexual dysfunction. J Clin Psychiatry Monograph. 1999;17:4-8.
4. Mathew RJ, Weinman M, Claghorn JL. Tricyclic side effects without tricyclics in depression. Psychopharmacol Bull. 1980; 16:58-60.
5. Casper RC, Redmond DE Jr, Katz MM, et al. Somatic symptoms in primary affective disorder: Presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42:1098-1104.
6. Kivelä S-L, Pahkala K. Clinician-rated symptoms and signs of depression in aged Finns. Int J Soc Psychiatry. 1988;34: 274-284.
7. Delgado PL, McGahuey CA, Moreno FA, et al. Treatment strategies for depression and sexual dysfunction. J Clin Psychiatry Monograph. 1999;17:15-21.
8. Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder: A controlled trial. Br J Psychiatry. 1987; 151:107-112.
9. Segraves RT. Treatment-emergent sexual dysfunction in affective disorder: A review and management strategies. J Clin Psychiatry Monograph. 1993;11:57-60.
10. Segraves RT. Antidepressant-induced orgasm disorder. J Sex Marital Ther. 1995; 21:192-201.
11. Montejo-González AL, Liorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23:176-194.
12. Modell JG, Katholi CR, Modell JD, DePalma RL. Pharmacoepidemiology and drug utilization: Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997;61:476-487.
13. Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry. 1998; 59(Suppl 4):48-54.
14. Masters WH, Johnson VE, Kolodny RC. Sexual physiology. In: Human Sexuality. 4th ed. New York: HarperCollins; 1992: 69-94.
15. Sadock VA. Psychosexual dysfunctions and treatment. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. 4th ed. Baltimore: Williams & Wilkins; 1985;1077-1090.
16. Segraves RT. Sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monograph. 1992;10:75-79.
17. Rényi L. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltriptamine-induced ejaculation in the rat. Br J Pharmacol. 1986;87:639-648.
18. Zemishlany Z. The effects of methylene-dioxymethamphetamine ("ecstasy") on human sexual function. In: Continuing Medical Education Syllabus and Scientific Proceedings in Summary Form, 149th Annual Meeting of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1996. Abstract NR712.
19. Zajecka J, Fawcett J, Schaff M, et al. The role of serotonin in sexual dysfunction: Fluoxetine-associated orgasm dysfunction. J Clin Psychiatry. 1991;52:66-68.
20. Sorscher SM, Dilsaver SC. Antidepressant-induced sexual dysfunction in men: Due to cholinergic blockade? J Clin Psychopharmacol. 1986;6:53-55. Letter.
21. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry. 1990; 51(Suppl B):28-33.
22. Herman JB, Brotman AW, Pollack MH, et al. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990;51:25-27.
23. Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry. 1985;46(Suppl 3, pt 2):53-58.
24. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry. 1993;54: 209-212.
25. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol. 1994;9(Suppl 1):19-26.
26. Ende J, Rockwell S, Glasgow M. The sexual history in general medicine practice. Arch Intern Med. 1984;144:558-561.
27. Patterson WM. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1993;54: 71. Letter.
28. Hsu JH, Shen WW. Male sexual side effects associated with antidepressants: A descriptive clinical study of 32 patients. Int J Psychiatry Med. 1995;25:191-201.
29. Benazzi F, Mazzoli M. Fluoxetine-induced sexual dysfunction: A dose-dependent effect? Pharmacopsychiatry. 1994;27:246.
30. Olivera AA. Sexual dysfunction due to clomipramine and sertraline: Nonpharmacological resolution. J Sex Educ Ther. 1994;20:119-122.
31. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry. 1995;152:1514-1516.
32. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol. 1999;19: 67-85.
33. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59:112-115.
34. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry. 1992;53:207-209.
35. Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia. J Clin Psychopharmacol. 1986;6:326-327. Letter.
36. DeCastro RM. Reversal of MAOI-induced anorgasmia with cyproheptadine. Am J Psychiatry. 1985;142:783. Letter.
37. McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51:383-384.
38. Shrivastava RK, Shrivastava S, Overweg N, Schmitt M. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1995; 15:83-84. Letter.
39. Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther. 1995;21:264-271.
40. Landén M, Eriksson E, Ågren H, Fahlén T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999;19:268-271.
41. Othmer E, Othmer SC. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry. 1987;48:201-203.
42. Norden MJ. Buspirone treatment of sexual dysfunction associated with selective serotonin re-uptake inhibitors. Depression. 1994;2:109-112.
43. Nurnberg HG, Lauriello J, Hensley PL, et al. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry. 1999;60:33-35.
44. Fava M, Rankin MA, Alpert JE, et al. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom. 1998;67:328-331.
45. Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry. 1993;54: 459-165.
46. Ferguson JM, Shrivastava RK, Stahl SM, et al. Effects of double-blind treatment with nefazodone or sertraline on re-emergence of sexual dysfunction in depressed patients. In: Continuing Medical Education Syllabus and Scientific Proceedings in Summary Form, 149th Annual Meeting of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1996. Abstract NR358.
47. Kavoussi RJ, Segraves RT, Hughes AR, et al. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry. 1997;58:532-537.
48. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry. 1996;57(Suppl 2):53-62.
49. Montgomery SA. Safety of mirtazapine: A review [published correction appears in Int Clin Psychopharmacol. 1996;11:153] Int Clin Psychopharmacol. 1995;10(Suppl 4):37-45.
50. Davidson JR, Tupler LA, Potts NL. Treatment of social phobia with benzodiazepines. J Clin Psychiatry. 1994;55(Suppl):28-32.
51. Terra JL, Montgomery SA. Fluvoxamine prevents recurrence of depression: Results of a long-term, double-blind, placebo controlled study. Int Clin Psychopharmacol. 1998;13:55-62.